Skip to main content
Clinical Trials/JPRN-UMIN000024014
JPRN-UMIN000024014Completed未知

Verification of the anti UV-induced inflammation effect of a plant extract ingredient. (Randomized, double-blind, placebo-controlled, parallel-group study) - Verification of the anti UV-induced inflammation effect of a plant extract.

Ezaki Glico Co., Ltd.0 sites40 target enrollmentStarted: September 13, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30years-old to 50years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Those with a diagnosis of photosensitive disorder. 2)Those who take drugs which affect skin photosensitivity. 3)Those with diagnosis of diseases on the measurement region by a medical advice. 4)Those whose MED was not detected in the measurements. 5)Those who have treated for beauty on the measurement region. 6)Those who routinely take foods, supplements and cosmetics that contain the same active ingredient. 7)Those who have treated for special skincare on the mesurement region or who have a plan to have the treatment within past 4 weeks. 8)Those who changed healthy foods or external preparation including basic skin-care products that use for measurement region, or who have begun usage of them within past 4 weeks. 9)Those who was exposed to exceeded UV-light than in daily life by activities including long hours of outwork, sports, sea bathing and leisure activities, or who have a plan it during the study period. 10)Those who engage in the night work and work in shifts day and night. 11)Those who are receiving the treatments to treat or prevent disease at medical institution at the time of receiving informed consent, or who have need of those therapy. 12)Those who have serious disorders of carbohydrate metabolism, lipid metabolism, liver function, kidney function, heart, cardiovascular, respiratory organs, endocrine system and nervous system, or with a history of psychiatric disorder. 13)Those with a history of alcoholic and drug dependency. 14)Those with allergies to cosmetics or foods. 15)Pregnant women, those who may be pregnant, lactating women at the time of receiving informed consent, or women who hope to become pregnant during the study period. 16)Those who have participated in other human studies similar to the study within past 2 months. 17)Those who have participated in other human studies within the past 4 weeks, or who plan to participate. 18)Those who were considered inappropriate for the study by an investigator.

Investigators

Similar Trials

Completed
Not Applicable
The inhibitory effects on "UV-induced inflammation and pigmentation " by ingestion of test food in human.
JPRN-UMIN000028847Iwase Cosfa Co., Ltd.90
Recruiting
Not Applicable
Evaluation of dressing materialHealthy adults
JPRN-UMIN000042177Kao Corporation20
Active, not recruiting
Not Applicable
ntersuchungen zur antipsoriatischen Wirkung der UVB-induzierten Synthese von 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol) in Keratinozyten läsionaler psoriatischer Haut unter Verwendung des Cytochrom-P (CYP) Inhibitors Ketokonazol - VITAKETHauptzielvariable ist die klinische Beurteilung der chronisch stationären Psoriasis vulgaris durch den intraindividuellen Vergleich der unterschiedlich behandelten Felder (Feld 1: UVB-Bestrahlung + adäquate, wirkstofffreie Grundlage Nizoral Creme) (Feld 2: UVB-Bestrahlung + Nizoral Creme)( Feld 3: unbehandelt) auf der Grundlage des lokalen PASI-Scores. Unterstützend werden hier die objektiven Parameter OCT und Ultraschall eingesetzt.
EUCTR2006-003590-27-DETechnical University Dresden, Department of Dermatology12
Completed
Not Applicable
on-invasive biomarkers of UV-radiatio10014982skin cancer
NL-OMON47995Academisch Medisch Centrum12
Completed
Not Applicable
The inhibitory effects on UV-induced skin deterioration by long-term ingestion of test food in human: a double-blind, randomized placebo-controlled, parallel comparison study
JPRN-UMIN000028925DRC Corporation, Ltd. Product Testing Department No.9 Tabuchi Bldg. 3F, 2-10-31, Higashi-Temma, Kita-ku, Osaka Tel: 81-(0)6-6882-113020
Verification of the anti UV-induced... | Clinical Trial